Healthcare & Biotech
ASX Stocks in Focus: 5 stocks built for an oil shock and sticky rates
5 stocks for inflation, AI and market volatility.
The Investor Standard – Your Investing Edge
Receive curated weekly stock picks, top-performing equities, and actionable investment ideas to maximise your portfolio potential.
Investor Insights, Delivered
Unlock expert insights, stock recommendations, and market analysis – all in one place. Get the latest market news and stock picks instantly.
Further Analysis & Commentary
WA Hospital Infrastructure Crisis
Ageing Assets Are Becoming an Economic Constraint Western Australia’s state government has released a sobering health infrastructure audit that goes…
Artrya (ASX: AYA) Investment Analysis: Can This AI-Driven Medtech Find Its Commercial Breakthrough?
Artrya has built its story around a simple but powerful problem. Heart disease remains the world’s leading killer, yet the…
ASX Diverges on Shocks: Banks Prop, Health & Tech Slide as Domino’s Pops, CSL Sinks
ASX Diverges on Shocks ASX diverges on shocks as headline-driven moves overwhelm the Wall Street lead. By late morning. the…
Cynata Therapeutics (ASX: CYP): Speculative Investment Analysis
Business Overview Cynata Therapeutics is a clinical-stage biotechnology company developing cell therapies based on Cymerus, its induced pluripotent stem cell…
Socials
Monthly Investor Memo
Delivered Monthly - 2026